Saltra™
Therapeutic Segment:
Anti-Asthmatic
Generic Name:
Salmeterol + Fluticasone propionate
Indication
Metered Dose Inhaler
- 25mcg + 125mcg
- 25mcg + 250mcg
Asthma (Reversible Obstructive Airways Disease):
For the regular treatment of asthma (Reversible Obstructive Airways Disease). This may include:
– Patients on effective maintenance doses of long-acting ß agonists and inhaled corticosteroids.
– Patients who are symptomatic on current inhaled corticosteroid therapy.
– Patients on regular bronchodilator therapy who require inhaled corticosteroids.
Chronic Obstructive Pulmonary Disease (COPD):
For the regular treatment of Chronic Obstructive Pulmonary Disease (COPD) including chronic bronchitis and emphysema.